Suppression of the Postoperative Neutrophil Leucocytosis Following Neoadjuvant Chemoradiotherapy for Rectal Cancer and Implications for Surgical Morbidity

Colorectal Disease - United Kingdom
doi 10.1111/j.1463-1318.2009.01858.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Analysis of Early Postoperative Morbidity Among Patients With Rectal Cancer Treated With and Without Neoadjuvant Chemoradiotherapy

Annals of Surgical Oncology
OncologySurgery
2007English

Rectal Perforation After Neoadjuvant Chemoradiotherapy for Low-Lying Rectal Cancer

BMJ Case Reports
Medicine
2015English

Neoadjuvant Chemoradiotherapy in Rectal Cancer

Memo - Magazine of European Medical Oncology
OncologyHematology
2020English

Neoadjuvant Long-Course Chemoradiotherapy for Rectal Cancer: Does Time to Surgery Matter?

International Surgery
Surgery
2015English

Neoadjuvant Chemoradiotherapy in Combined Treatment of Patients With Rectal Cancer

Grekov's Bulletin of Surgery
2017English

Recent Advances in Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Journal of the Anus, Rectum and Colon
2017English

Open Versus Laparoscopic Surgery for Low Rectal Cancer After Neoadjuvant Chemoradiotherapy: Short-Term Outcomes

Nippon Daicho Komonbyo Gakkai Zasshi
2012English

Prediction of Efficacy of Neoadjuvant Chemoradiotherapy for Rectal Cancer: The Value of Texture Analysis of Magnetic Resonance Images

Abdominal Radiology
Nuclear MedicineRadiologyUrologyUltrasound TechnologyGastroenterologyRadiologicalImaging
2019English

The Role of Oxaliplatin in Chemoradiotherapy for Rectal Cancer

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy